Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2025-06-11 00:00:00 ET · period of report 2025-06-10 · accession 0001415889-25-016739 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-11 | 2025-06-10+ | ORIC | Piscitelli Dominic | CFO | S - Sale | $10.01 | -3,300 | 103.8K | -3% | -$33.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-10 | S | D | 324 | $10.00 | 105,093 | D | — | — | (F2) Includes an aggregate of 1,553 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-06-11 | S | D | 1,700 | $10.01 | 102,117 | D | — | — | |
| 3 | Common | Common Stock | 2025-06-11 | S | D | 1,276 | $10.00 | 103,817 | D | — | — |